S10 - "Best Of" Session: MS and CNS Inflammatory Disease

Event Time: Monday April 24, 2017 8:00 am to 9:00 am
Topic(s): MS and CNS Inflammatory Disease
Director(s):
Description: A platform session that brings together the top four scoring abstracts in a particular topic, as rated by the topic reviewers. Offers an opportunity to interact with the author in a smaller setting at the conclusion of the session.
Completion Message:
CME Credits: 1
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
8:00 AM 001 Longitudinal characterization of cortical lesion evolution in multiple sclerosis by ultra high field MRI Constantina A Treaba
Disclosure:
Dr. Treaba has nothing to disclose.

8:08 AM 002 Durable Reduction in MRI Disease Activity With Alemtuzumab in the Absence of Continuous Treatment in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Were Treatment-Naive: 6-Year Follow-up of the CARE-MS I Study Douglas L Arnold, MD
Disclosure:
Dr. Arnold has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Biogen, F. Hoffmann-La Roche Ltd, MedDay, MedImmune, Mitsubishi, Novartis, Receptos/Celgene, Sanofi-Aventis. Dr. Arnold has received compensation for serving on the Board of Directors of NeuroRx Research.

8:16 AM 003 Environmental risk factors associated with pediatric MS: The role of remote viral infections and vitamin D revisited. Shayandokht Taleb, MD
Disclosure:
Dr. Taleb has nothing to disclose.

8:24 AM 004 Self-reported fatigue and lower limb problems predictive of conversion to secondary progressive multiple sclerosis in an aging sample of patients Caila Vaughn
Disclosure:
Dr. Vaughn has nothing to disclose.

Register Now

Related Courses